News & Updates

Gestational carriers, or surrogate mothers, are at increased risk for severe maternal morbidity (SMM) and adverse pregnancy outcomes than women who conceived with and without assistance, reports a recent study.

In women with severe symptomatic aortic stenosis (AS), transcatheter aortic valve implantation (TAVI) is superior to conventional surgery in terms of reducing death, stroke, and rehospitalization at 1 year, according to the RHEIA* trial presented at ESC 2024.

In the treatment of patients with relapsed or persistent ovarian clear cell carcinoma, the combination of sintilimab plus bevacizumab has demonstrated promising antitumour activity and manageable safety in the phase II INOVA trial.

Treatment with a single dose of tamsulosin prior to minimally invasive hysterectomy for benign conditions does not shorten postoperative time to void or time to discharge, as reported in a study.